1 |
Efficacy and safety of recombinant E. coli
asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group |
|
|
| Inge M. van der Sluis,Hester de Groot-Kruseman,Maroeska te Loo,Wim J.E. Tissing,Cor van den Bos,Gertjan J.L. Kaspers,Marc Bierings,Wouter J.W. Kollen,Thorsten König,Uwe Pichlmeier,Hans-Jürgen Kühnel,Rob Pieters |
|
| Pediatric Blood & Cancer. 2018; : e27083 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA) |
|
|
| Erick Crespo-Solis,Karla Espinosa-Bautista,Martha Alvarado-Ibarra,Etta Rozen-Fuller,Fernando Pérez-Rocha,Chantal Nava-Gómez,Maricela Ortiz-Zepeda,José Luis Álvarez-Vera,Christian Omar Ramos-Peñafiel,Luis Antonio Meillón-García,Sergio Rodríguez-Rodríguez,Alan Pomerantz-Okon,Francisco Javier Turrubiates-Hernández,Roberta Demichelis-Gómez |
|
| Cancer Medicine. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Microbial cell disruption methods for efficient release of enzyme L-asparaginase |
|
|
| Tales A. Costa-Silva,Juan Carlos Flores-Santos,Rominne K. B. Freire,Michele Vitolo,Adalberto Pessoa-Jr |
|
| Preparative Biochemistry and Biotechnology. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry |
|
|
| Fatemeh Izadpanah Qeshmi,Ahmad Homaei,Pedro Fernandes,Sedigheh Javadpour |
|
| Microbiological Research. 2018; 208: 99 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant l.Asparaginase |
|
|
| Hesham Saeed,Hadeer Soudan,Amany El-Sharkawy,Aida Farag,Amira Embaby,Farid Ataya |
|
| The Protein Journal. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Small Molecule Catalysts with Therapeutic Potential |
|
|
| Yannick Ney,Muhammad Jawad Nasim,Ammar Kharma,Lama Youssef,Claus Jacob |
|
| Molecules. 2018; 23(4): 765 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase |
|
|
| Elizabeth R. Tang,Teresa Chapman,Laura S. Finn,Kasey J. Leger |
|
| Radiology Case Reports. 2018; 13(3): 568 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Improving the Efficiency of V?9Vd2 T-Cell Immunotherapy in Cancer |
|
|
| Timm Hoeres,Manfred Smetak,Dominik Pretscher,Martin Wilhelm |
|
| Frontiers in Immunology. 2018; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma |
|
|
| G K Abou-Alfa,S Qin,B-Y Ryoo,S-N Lu,C-J Yen,Y-H Feng,H Y Lim,F Izzo,M Colombo,D Sarker,L Bolondi,G Vaccaro,W P Harris,Z Chen,R A Hubner,T Meyer,W Sun,J J Harding,E M Hollywood,J Ma,P J Wan,M Ly,J Bomalaski,A Johnston,C-C Lin,Y Chao,L-T Chen |
|
| Annals of Oncology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors |
|
|
| Alexandra Louka,Irina Matlahov,Stefano Giuntini,Linda Cerofolini,Andrea Cavallo,Serena Pillozzi,Enrico Ravera,Marco Fragai,Annarosa Arcangeli,Ayyalusamy Ramamoorthy,Gil Goobes,Claudio Luchinat |
|
| Physical Chemistry Chemical Physics. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Glutaminase free l -asparaginase from Vibrio cholerae : Heterologous expression, purification and biochemical characterization |
|
|
| Remya Radha,Nagarajan Arumugam,Sathyanarayana N. Gummadi |
|
| International Journal of Biological Macromolecules. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature |
|
|
| Alison Blackman,Alyssa Boutin,Alexei Shimanovsky,William J Baker,Nicholas Forcello |
|
| Journal of Oncology Pharmacy Practice. 2018; 24(5): 393 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Rhodospirillum rubrum l -asparaginase targets tumor growth by a dual mechanism involving telomerase inhibition |
|
|
| Dmitry D. Zhdanov,Vadim S. Pokrovsky,Marina V. Pokrovskaya,Svetlana S. Alexandrova,Mikhail A. Eldarov,Dmitry V. Grishin,Marsel M. Basharov,Yulia A. Gladilina,Olga V. Podobed,Nikolai N. Sokolov |
|
| Biochemical and Biophysical Research Communications. 2017; 492(2): 282 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Targeting Metabolism for Cancer Therapy |
|
|
| Alba Luengo,Dan Y. Gui,Matthew G. Vander Heiden |
|
| Cell Chemical Biology. 2017; 24(9): 1161 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors |
|
|
| Gabriela Andrejeva,Jeffrey C. Rathmell |
|
| Cell Metabolism. 2017; 26(1): 49 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Therapeutic Drug Monitoring of Asparaginase Activity - Method Comparison of MAATTM and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial |
|
|
| Claudia Lanvers-Kaminsky,Andrea Rüffer,Gudrun Würthwein,Joachim Gerss,Massimo Zucchetti,Andrea Ballerini,Andishe Attarbaschi,Petr Smisek,Christa Nath,Samiuela Lee,Sara Elitzur,Martin Zimmermann,Anja Möricke,Martin Schrappe,Carmelo Rizzari,Joachim Boos |
|
| Therapeutic Drug Monitoring. 2017; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Asparaginase pharmacology: challenges still to be faced |
|
|
| Claudia Lanvers-Kaminsky |
|
| Cancer Chemotherapy and Pharmacology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
L-Asparaginase for newly diagnosed extra-nodal NK/T-cell lymphoma: systematic review and meta-analysis |
|
|
| Vadim S. Pokrovsky,Denis Vinnikov |
|
| Expert Review of Anticancer Therapy. 2017; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
19 |
Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions |
|
|
| Daiki Karigane,Keiyo Takubo |
|
| International Journal of Hematology. 2017; 106(1): 18 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
20 |
Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations |
|
|
| Zeina N Al-Mahayri,George P Patrinos,Bassam R Ali |
|
| Pharmacogenomics. 2017; 18(7): 687 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
21 |
Treatment of Young Adults with Acute Lymphoblastic Leukemia |
|
|
| Ankit Kansagra,Mark Litzow |
|
| Current Hematologic Malignancy Reports. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
22 |
Emerging biological therapies to treat acute lymphoblastic leukemia |
|
|
| Françoise Huguet,Suzanne Tavitian |
|
| Expert Opinion on Emerging Drugs. 2016; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|